References
- Weatherall DJ, Akinyanju O, Fucharoen S, et al. Inherited disorders of hemoglobin. In: Jamison D, Breman J, Measham A, et al. Eds. Disease Control Priorities in Developing Countries, 2nd ed. New York: Oxford University Press. 2006:663–680
- Harteveld CL, Higgs DR. α-Thalassaemia. Orphanet J Rare Dis. 2010;5:13
- Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537–D541
- Ghassemifar R, Forster L, Qadah T, Finlayson J. Identification and characterization of two novel and differentially expressed isoforms of human α2- and α1-globin genes. Hemoglobin. 2012;36(5):421–432
- Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev. 2003;17(4):419–437
- Qadah T, Finlayson J, Newbound C, et al. A molecular tool to assess the pathological relevance of α-globin DNA variants. Pathology. 2012;44(4):337–341
- Tan AS, Quah TC, Low PS, Chong SS. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for α-thalassemia. Blood. 2001;98(1):250–251
- Hebsgaard SM, Korning PG, Tolstrup N, et al. Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res. 1996;24(17):3439–3452
- Gasteiger E, Gattiker A, Hoogland C, et al. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003;31(13):3784–3788
- Qadah T, Finlayson J, Ghassemifar R. In vitro characterization of the α-thalassemia point mutation HBA2: c.95 + 1G>A [IVS-I-1 (G>A) (α2)]. Hemoglobin. 2012;36(1):38–46
- Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet. 2005;42(10):737–748
- Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 2002;3(4):285–298
- Cooper TA, Wan L, Dreyfuss G. RNA and disease. Cell. 2009;136(4):777–793
- Houdayer C, Dehainault C, Mattler C, et al. Evaluation of in silico splice tools for decision-making in molecular diagnosis. Hum Mutat. 2008;29(7):975–982
- Qadah T, Finlayson J, Newbound C, et al. Molecular and cellular characterization of a new α-thalassemia mutation (HBA2: c.94A>C) generating an alternative splice site and a premature stop codon. Hemoglobin. 2012;36(3):244–252
- Orkin SH, Goff SC, Hechtman RL. Mutation in an intervening sequence splice junction in man. Proc Natl Acad Sci USA. 1981;78(8):5041–5045
- Harteveld CL, Beijer C, van Delft P, et al. α-Thalassaemia as a result of a novel splice donor site mutation of the α1-globin gene. Br J Haematol. 2000;110(3):694–698
- Waye JS, Eng B, Dutly F, Frischknecht H. α-Thalassemia caused by two novel splice mutations of the α2-globin gene: IVS-I-1 (G>A and G>T). Hemoglobin. 2009;33(6):519–522
- Silva AL, Pereira FJ, Morgado A, et al. The canonical UPF1-dependent nonsense-mediated mRNA decay is inhibited in transcripts carrying a short open reading frame independent of sequence context. RNA. 2006;12(12):2160–2170
- Chaisue C, Kitcharoen S, Wilairat P, et al. α/β-Globin mRNA ratio determination by multiplex quantitative real-time reverse transcription-polymerase chain reaction as an indicator of globin gene function. Clin Biochem. 2007;40(18):1373–1377